ISSN: 2161-1173
Anaplastology
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
 
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Metastatic Renal Cell Carcinoma to Submandibular Gland: A Rare Occurrence

Carlo Melloni1*, Nino Dispensa2, Adriana Tuttolomondo1*, Guglielmo Melloni3 and Adriana Cordova1*
1Department of Surgical, Oncological and Oral Sciences, Plastic and Reconstructive Surgery Unit, University of Palermo, Italy
2Department of Medicine, Cardiovascular and Nephrourological Disease – Urology, University of Palermo Italy
3Division of Urology, Department of Surgical Sciences, Molinette Hospital, University of Studies of Turin Italy University of Palermo, Italy
Corresponding Author : Carlo Melloni, M.D
Department of Surgical
Oncological and Oral Sciences
Plastic and Reconstructive Surgery Unit
University of Palermo, Italy
Tel: +39 091 6554034
Fax: +39 091 6553720
E-mail: carlomelloni.unipa@gmail.com
Received date: April 25, 2015, Accepted date: September 1, 2015, Published date: September 5, 2015
Citation:Melloni C, Dispensa N, Tuttolomondo A, Melloni G, Cordova A (2015) Metastatic Renal Cell Carcinoma to Submandibular Gland: A Rare Occurrence . Anaplastology 4:151. doi:10.4172/2161-1173.1000151
Copyright: © 2015 Melloni C, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at Pubmed, Scholar Google

Visit for more related articles at Anaplastology

Abstract

Approximately 20-30% of patients affected by renal cell carcinoma (RCC) present with metastatic disease, and 20% to 40% undergoing nephrectomy for clinically localized disease will develop metastases. A 53 years old female patient developed a left submandibular swelling. Four years before she experienced a left radical nephrectomy for a clear cell tumor and two years later right kidney was removed for a cancer having the same histologic subtype. In that circumstance duodenal pancreasectomy was required for infiltration of pancreatic gland. A sialoadenectomy has been performed and pathology demonstrated an intraglandular neoplasm with characteristics of a clear renal cell carcinoma. Although it is extremely rare, submandibular salivary gland may be a site of RCC metastasis. Diagnosis of metastatic disease for patients affected by submandibular swelling with a previous history of RCC should be always considered.

Keywords
Clear cell renal carcinoma; Metastasis; Submandibular gland; Salivary gland metastasis
Introduction
RCC is an unpredictable tumor because of its clinical behavior and high metastatic potential. It accounts for 3% of all malignancies and is the most deadly urological malignancy with only 62% of the patients surviving 5 years in all stages. It can metastasize to any location in the body, and its propensity to metastasize to unusual sites has been well documented. Approximately 20-30% of patients present with metastatic disease and 20% to 40% undergoing nephrectomy, for clinically localized RCC, will develop metastases [1]. The proportion of occurrence with distant metastases increased with tumor size, T category and Fuhrman grade. According data of Swedish Kidney Cancer Registry [2] RCCs have an aggressive potential, resulting in distant metastases even in tumor of 1-2 cm in size. In other published series no patients with RCC developed metastases after surgery for a tumor <2 cm during a median follow up of 7 years [3].
The most commonly involved organ is the lung, then lymph nodes, liver, bones, adrenal glands, opposite kidney, brain, heart, spleen, intestine, and skin follow with decreasing frequency in this order. It has long been known that RCC produces metastases of very unusual location and presentation.
Bennington and Beckwith gave an exhaustive and complete description of the differential diagnosis of metastases of RCC in 1975. In conclusion, secondary lesions arising from RCC may involve nearly every organ, including salivary glands [4]. Literature reports a predominance of parotid gland metastasis; submandibular salivary gland is a rare site of metastasis and descriptions are limited to few case reports.
Case Report
A 53 years old female patient developed a left submandibular swelling (Figure 1).
The patient was initiated on hemodialysis as consequence of bilateral nephrectomy. In fact, 4 years before, she experienced a left radical nephrectomy for a clear cell tumor and 2 years later right kidney was also removed for a cancer having the same pathological figure. In that circumstance, duodenal pancreasectomy was required for infiltration of pancreatic gland. The submandibular lesion looked rounded, measured about 4 cm in diameter; it had a hard consistency and was fixed and painful.
Preoperatively US of the swelling and head-neck CT scan with 3D rendering (Figure 2).
Demonstrated a submandibular gland increased in size, hypoechoic, with regular edges and homogeneous density. Fine needle aspiration and cytology showed us a “papillary cystadenoma lymphomatosum”. This benign neoplasm with its intimidating histologic name, also called Warthin’s tumor, is the second most common benign salivary gland neoplasm. Although it can occur elsewhere, it most commonly arises in the parotidgland (the only tumor virtually restricted to the parotid). Sialoadenectomy with marginal mandibular nerve sparing surgery were performed and histology demonstrated an intraglandular neoplasm referred to clear RCC metastasis.
Discussion
Metastatic renal cell carcinoma has a poor prognosis. Despite advances in biological and immune-based therapies, response rate for patients with metastatic RCC remain at about 15 to 25%. About 75% of patients with metastatic renal carcinoma have metastases to the lung, 36% to the soft tissues, 20% to bone, 18% to liver, 8% to cutaneous sites and 8% to the central nervous system. Even if reported infrequently, head and neck region metastases may be linked to RCC in up to 8– 15% of cases [1,5]. Complete removal of metastatic lesions, if technically feasible, can contribute to an improvement of clinical prognosis. In patients with synchronous metastatic spread, metastasectomy should be performed in case of resectable disease and good performance status, although the clinical prognosis is worse when compared with the occurrence of asynchronous metastases. Treatment of RCC metastasis in the head and neck is directed mainly towards palliation [6]. Excision is usually performed to control pain and to manage any potential complications from a space occupying mass in the head and neck region, including the brain. Reports of RCC in the head and neck region involve those in the nose, tongue, paranasal sinuses, larynx, mandible, temporal bone and thyroid gland [7,8]. The location of metastasis usually dictates the presenting symptoms [9]. In the oral cavity, the majority of metastases occur to the bones, especially involving the jaw. Only in 33% of the cases are they seated in soft tissues, and this is usually associated with a bad prognosis. Submandibular salivary gland metastases are extremely rare and commonly referred to parotid gland. In our patient radiological and cytological findings have not been able to distinguish between benign or malignant disease and the presurgical diagnosis was Warthin’s tumor. The mistake derived from oncocityc appearance of Warthin’s tumor. Oncocytes are epithelial cells stuffed with mitochondria, which impart the granular appearance to the cytoplasm. Cytological sample showed neoplastic epithelial cells having an abundant, finely granular, eosinophilic cytoplasm. Nevertheless, lymphoid elements were absent while Warthin’s tumor usually shows a dense lymphoid stroma or follicular germinal center beneath the epithelium. Immunohistochemical findings of the surgical specimen confirmed a clear RCC metastasis. In fact, cancer cells shoved CD10- positivity, vimentin and cytocheratin 8/10 coexpression, CEA and S100-negativity.
Conclusion
Although it is extremely rare, submandibular salivary gland may be a site of RCC metastasis. Accordingly, metastatic disease should be considered in the differential diagnosis for patients affected by submandibular swelling with a previous history of RCC. Radiological and cytological findings may not distinguish between primary and metastatic disease and the definitive diagnosis may derive only by pathological and immunohistochemical findings. Histologically differentiating among clear cell tumors with conventional light microscopy can be challenging. It can be especially difficult to distinguish between RCC metastasis and clear cell malignancies of the salivary glands, such as, acinic cell neoplasm, clear cell oncocytoma, mucoepidermoid carcinoma, primary clear-cell carcinoma and epithelial-myoepithelial carcinoma [9]. Immunohistochemical staining helps in this distinction,with RCC metastasis exhibiting focal cytokeratin positivity (versus minor salivary gland cancers showing diffuse positivity) and a strong reaction for vimentin [10].
References










Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 11221
  • [From(publication date):
    October-2015 - Jul 30, 2016]
  • Breakdown by view type
  • HTML page views : 7482
  • PDF downloads :3739
 
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsinc.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsinc.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsinc.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsinc.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsinc.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsinc.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsinc.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsinc.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsinc.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsinc.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsinc.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsinc.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsinc.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsinc.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsinc.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsinc.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version